The Civilian Oversight Commission is raising concerns about a previously unknown deputy subgroup that oversight officials say uses a logo featuring Nazi-like imagery, according to a memo obtained by ...
Nouscom has also exclusively out-licensed VAC-85135, an off-the-shelf immunotherapy developed under a multi-project agreement, which is currently under evaluation in a Phase 1 trial for the treatment ...
This milestone represents significant progress in Ferring's manufacturing capabilities to meet anticipated growth in demand for Adstiladrin (nadofaragene firadenovec-vncg), a gene therapy for people ...